Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Otterson

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|January 8, 2015
Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancerWenrui Duan, Li Gao, Brittany Aguila, et al.
Experimental Cell Research|August 29, 2006
Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cellsWenrui Duan, Li Gao, Xin Wu, et al.
Cardio-Oncology (London, England)|January 18, 2023
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case reportAnkur Sheel, Junu Bae, Ashlee Asada, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2011
A pilot test of a combined tobacco dependence treatment and lung cancer screening programAmy K Ferketich, Gregory A Otterson, Mark King, et al.
Oncotarget|July 1, 2016
Lung cancer exosomes as drivers of epithelial mesenchymal transitionMohammad A Rahman, Jennifer F Barger, Francesca Lovat, et al.
Oncotarget|April 12, 2014
Molecular pathways and therapeutic targets in lung cancerEmma Shtivelman, Thomas Hensing, George R Simon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic CarcinomaDwight Owen, Benjamin Chu, Amy M Lehman, et al.
Oncotarget|February 12, 2015
Overexpression of Rad51C splice variants in colorectal tumorsArjun Kalvala, Li Gao, Brittany Aguila, et al.
JTO Clinical and Research Reports|September 30, 2021
A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, <i>RET</i>-Rearranged NSCLCJustin F Gainor, Shirish Gadgeel, Sai-Hong I Ou, et al.
Biochemical and Biophysical Research Communications|May 28, 2003
P21 response to DNA damage induced by genistein and etoposide in human lung cancer cellsHaiming Ding, Wenrui Duan, Wei-Guo Zhu, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|January 8, 2015
Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancerWenrui Duan, Li Gao, Brittany Aguila, et al.
Experimental Cell Research|August 29, 2006
Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cellsWenrui Duan, Li Gao, Xin Wu, et al.
Cardio-Oncology (London, England)|January 18, 2023
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case reportAnkur Sheel, Junu Bae, Ashlee Asada, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2011
A pilot test of a combined tobacco dependence treatment and lung cancer screening programAmy K Ferketich, Gregory A Otterson, Mark King, et al.
Oncotarget|July 1, 2016
Lung cancer exosomes as drivers of epithelial mesenchymal transitionMohammad A Rahman, Jennifer F Barger, Francesca Lovat, et al.
Oncotarget|April 12, 2014
Molecular pathways and therapeutic targets in lung cancerEmma Shtivelman, Thomas Hensing, George R Simon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic CarcinomaDwight Owen, Benjamin Chu, Amy M Lehman, et al.
Oncotarget|February 12, 2015
Overexpression of Rad51C splice variants in colorectal tumorsArjun Kalvala, Li Gao, Brittany Aguila, et al.
JTO Clinical and Research Reports|September 30, 2021
A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, <i>RET</i>-Rearranged NSCLCJustin F Gainor, Shirish Gadgeel, Sai-Hong I Ou, et al.
Biochemical and Biophysical Research Communications|May 28, 2003
P21 response to DNA damage induced by genistein and etoposide in human lung cancer cellsHaiming Ding, Wenrui Duan, Wei-Guo Zhu, et al.
Pageof 16